Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

The Small Cap Wrap: Lumos Diagnostics launches BARDA-backed paediatric study for FebriDx in US; Tamboran secures NT Government approval for gas sales...

The S&P/ASX 200 ended lower on Monday, slipping 45.40 points, or 0.51%, to close at 8,927.70. Among the weakest performers were Mesoblast Limited, down 7.80%, and Generation Development Group Limited, which fell 7.75%. Over the past five days, the benchmark index has shed 0.44% and now sits 1.40% below its 52-week peak.

Meanwhile, the S&P/ASX Small Ordinaries (XSO) index gained 20.40 points, or 0.56%, to 3,631.80, advancing 1.95% across the last week.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK